StonvexLoading…
StonvexStonvexStonvexCore line items from EOG's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
Quarterly filings sourced directly from SEC EDGAR. Real-time earnings actuals are in the Earnings panel above.
| Metric | Annual 2025 2025-12-31 | Annual 2024 2024-12-31 | Annual 2023 2023-12-31 | Annual 2022 2022-12-31 |
|---|---|---|---|---|
Revenue | $22.63B | $23.70B | $24.19B | $25.70B |
Operating Income | $6.38B | $8.08B | $9.60B | $9.97B |
Net Income | $4.98B | $6.40B | $7.59B | $7.76B |
EPS (Diluted) | $9.12 | $11.25 | $13.00 | $13.22 |
Total Assets | $51.80B | $47.19B | $43.86B | $41.37B |
Total Liabilities | Not available | Not available | Not available | Not available |
Cash & Equivalents | $3.40B | $7.09B | $5.28B | $5.97B |
Free Cash Flow OCF − CapEx | Not available | Not available | Not available | Not available |
Shares Outstanding | 546.00M | 569.00M | 584.00M | 587.00M |